How to Buy Rapport Therapeutics Stock
Rapport Therapeutics Inc
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders.
Rapport Therapeutics stock last closed at $25.05, up 3.47% from the previous day, and has decreased 6.81% in one year. It has overperformed other stocks in the Biotechnology industry by 0.6 percentage points. Rapport Therapeutics stock is currently +13.55% from its 52-week low of $22.06, and -52.67% from its 52-week high of $52.93.
There are currently 47.98M RAPP shares outstanding. The market capitalization of RAPP is $1.20B. In the last 24 hours, 922,000 RAPP shares were traded.
How to Buy Rapport Therapeutics Stock
Wondering how to invest in Rapport Therapeutics stock? Here's how.
- Choose where to buy Rapport Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Rapport Therapeutics stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Select your method of payment and add your details.
- Evaluate Rapport Therapeutics stock: The Rapport Therapeutics ticker symbol is RAPP. Is Rapport Therapeutics stock a good investment? Should you buy shares of RAPP? How do RAPP's underlying business fundamentals look? Do top analysts think Rapport Therapeutics is a good buy? Why has RAPP's stock price moved recently? (Hint: Our stock research website can help you evaluate if RAPP is a good stock to buy).
- Make your RAPP buy order: Decide if you will purchase RAPP shares at the current market price or use a limit order to purchase RAPP stock at a specific price.
- Keep an eye on your RAPP investment: Create a watchlist to track your investment in Rapport Therapeutics stock.
Step 1: Choose where to buy Rapport Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy RAPP stock.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you can invest in RAPP today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've finished signing up on stock market apps, you can securely and quickly fund your account:
Check out the video below for more details depositing funds into your new brokerage account.
Step 4: Evaluate Rapport Therapeutics stock
After you have identified the best place to buy Rapport Therapeutics stock, it's important to research their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.
Rapport Therapeutics stock quick numbers
RAPP Due Diligence Score
WallStreetZen was created to help average investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on RAPP's stock page.
What is the fair value of RAPP stock?
Investors use many financial metrics, analyses, models, and charts to gauge RAPP's intrinsic value.
Using relative valuations ratios:
- RAPP may be undervalued based on its P/B ratio of 2.84x, relative to Biotechnology industry P/B ratio of 5.2x
You can do additional valuation analysis on RAPP's stock here.
Is RAPP a healthy company?
Positive Health Checks:
- RAPP has $436.18M in cash and short term investments. This is enough to cover its annual cash burn of $96.96M.
- RAPP has cash burn of 96956000. It has sufficient cash and short-term investments to cover this for at least one year.
- RAPP has a low debt to equity ratio of 0.09.
- There are more short-term assets than short-term liabilities on the RAPP balance sheet.
- There are more short-term assets than long-term liabilities on the RAPP balance sheet.
Negative Health Checks:
- RAPP profit margin has gone down from N/A to -685.8% in the past year.
Is it a good time to buy Rapport Therapeutics stock, according to Wall Street analysts?
Out of 8 Equities analysts who research RAPP, the consensus analyst rating on Rapport Therapeutics is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent RAPP Analyst Ratings
Joon Lee, a top 2% analyst from UBS initiates coverage on RAPP with a strong buy rating and announces their RAPP price target of $71.00, on Oct 15, 2026.
An analyst from Wolfe Research initiates coverage on RAPP with a buy rating and announces their RAPP price target of $50.00, on Oct 15, 2026.
Marc Goodman, a top 9% analyst from Leerink Partners initiates coverage on RAPP with a buy rating and announces their RAPP price target of $52.00, on Jun 24, 2026.
Danielle Brill, a top 14% analyst from Truist Securities assumes RAPP with a strong buy rating and raises their RAPP price target from $44.00 to $56.00, on May 19, 2026.
Truist Securities's Danielle Brill assumed coverage on Rapport Therapeutics (NASDAQ: RAPP) with a Strong Buy rating. The analyst also raised their price target by 27.3% from $44 to $56.
Assuming coverage on Rapport Therapeutics, Brill backgrounded that RAP-219 is an attractive, differentiated epilepsy asset, with early efficacy data suggestive of best-in-category potential in focal-onset seizures.
Upside optionality in bipolar mania is also visible, the analyst said, which is not reflected in its current projections.
You can dive deeper into what analysts are saying on the Rapport Therapeutics stock forecast page.
RAPP Momentum
What are RAPP executives and large shareholders up to?
Over the past 12 months, insiders at RAPP have sold more shares than they have bought.
Ramiro Sanchez, Director of RAPP, was the latest RAPP insider to buy. They bought $98,478.00 worth of RAPP stock on Oct 23, 2026.
Dig into more about who owns RAPP shares here.
Does RAPP provide a stable income stream?
No, Rapport Therapeutics doesn't provide an income stream by paying out dividends.
RAPP Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your RAPP buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, use a limit order.
Click the Open Trade button and eToro will place the order.
If you require additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your RAPP investment
Now that you own some RAPP shares, you'll want to stay up-to-date on your new shares.
Add RAPP to a watchlist to keep track of your RAPP stock.
RAPP Feed
How to Buy Stock in Rapport Therapeutics
To reiterate, here are the 6 steps for buying Rapport Therapeutics stock:
- Choose where to buy Rapport Therapeutics stock
- Open your brokerage account
- Fund your investment account
- Evaluate Rapport Therapeutics stock
- Make your RAPP buy order
- Keep an eye on your RAPP investment
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest news on your investment in Rapport Therapeutics, create your watchlist below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.